Close
ACHEMA MIDDLE EAST 2026

Gut Microbiota Is Important In Parkinsons, As Per A Study

Metagenomics, the study of genetic material extracted directly from the stool microbiomes of people with PD and neurologically healthy control participants, was used by...

Life-Changing Potential of Artificial Pancreas Technology

Innovative technology could help people with Type 1 diabetes who can't control their condition, and it will be made available to them. Additionally, the...

Significant M&A Agreements Are On The Horizon For 2023

According to EY's 2023 M&A Firepower report, the life sciences sector has record levels of deal-making Firepower, which measures a company's ability to undertake...

A Breakthrough Medication For Dystonia Is Being Developed

Thousands of musicians now have hope after substantial progress was made in the search for a dystonia cure by a research team in Korea. 1–3%...

Australia Introduces A New Tool To Lower Medicine Costs

Millions of Australians will pay up to 29% less for their Pharmaceutical Benefits Scheme (PBS) prescriptions because the maximum PBS co-payment is going down...

Hong Kong University Creates Bone Anabolic Aptamer Drug

The molecular target for bone anabolic therapy has been discovered by a research team headed by Hong Kong Baptist University (HKBU), utilising a particular...

Cancer Treatment Rates In NHS Hit An All-Time High In 2022

The NHS has released encouraging statistics regarding cancer rates in the UK to kick off the new year. Over the past year, more patients...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...